 Evelo Biosciences, Inc. EVLO, a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Thursday, June 4th at 4:30 p.m. ET. Evelo Biosciences is a clinical stage biotechnology company developing oral biologics that act on SINTAXTM, the small intestinal axis, with systemic therapeutic effects. The companys first product candidates are monoclonal microbials, single strains of microbes selected for defined pharmacological properties. 